1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Tc99m-tilmanocept: new trials by email Literature Review of Tc99m-tilmanocept trials Research Report on Tc99m-tilmanocept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA Tc99m-tilmanocept, SPECT Imaging (60 Minutes post-injection), SPECT Imaging (180 Minutes post-injection) - Arthritis, Rheumatoid | Phase 1 / Phase 2 | Completed | Navidea Biopharmaceuticals | 39 | 2017-01-01 | 2021-08-12 |
Navidea Biopharmaceuticals (1)
United States (1)
Micheal Blue, MD (1)